# Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma

> **NCT02029573** · PHASE2 · COMPLETED · sponsor: **King Fahad Medical City** · enrollment: 36 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Temozolomide
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT02029573
- **Lead sponsor:** King Fahad Medical City
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02029573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02029573, "Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02029573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*